FDA label

What is Syndros used for?

Syndros contains dronabinol. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label says: “SYNDROS is indicated in adults for the treatment of: anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS); nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.”

Run it in Rivvi

Which 2027 plans near you dropped or restricted Syndros?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Syndros, solution

Indications and Usage, quoted from the label by Benuvia Operations, LLC (NDA205525). Cross-references to other label sections are left out.

SYNDROS is indicated in adults for the treatment of:

  • anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS).
  • nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.

Source: DailyMed label, set id a7801c70-995d-46a2-91ee-141ef427c6b5, version 9, effective April 21, 2026. NDC 78613-201, one of 2 listings for this product.

Questions

What is Syndros used for?

The FDA label says: “SYNDROS is indicated in adults for the treatment of: anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS); nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.”

What drug class is Syndros?

FDA lists dronabinol in the Cannabinoid established pharmacologic class.

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Syndros

Try it on your own data today.

Free to start. Most teams are using it the same day.